Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.

Sprenger HG, Wani G, Hesseling A, König T, Patron M, MacVicar T, Ahola S, Wai T, Barth E, Rugarli EI, Bergami M, Langer T

Open source

DOI
10.15252/emmm.201809288
Published
2019 Jan
Container
EMBO molecular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15252/emmm.201809288,
  title = {Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.},
  author = {Sprenger HG and Wani G and Hesseling A and König T and Patron M and MacVicar T and Ahola S and Wai T and Barth E and Rugarli EI and Bergami M and Langer T},
  year = {2019},
  journal = {EMBO molecular medicine},
  doi = {10.15252/emmm.201809288},
  url = {https://doi.org/10.15252/emmm.201809288}
}

RIS

TY  - JOUR
TI  - Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.
AU  - Sprenger HG
AU  - Wani G
AU  - Hesseling A
AU  - König T
AU  - Patron M
AU  - MacVicar T
AU  - Ahola S
AU  - Wai T
AU  - Barth E
AU  - Rugarli EI
AU  - Bergami M
AU  - Langer T
PY  - 2019
JO  - EMBO molecular medicine
DO  - 10.15252/emmm.201809288
UR  - https://doi.org/10.15252/emmm.201809288
ER  - 

APA

HG, S., G, W., A, H., T, K., M, P., T, M., S, A., T, W., E, B., EI, R., M, B., & T, L. (2019). Loss of the mitochondrial i-AAA protease YME1L leads to ocular dysfunction and spinal axonopathy.. EMBO molecular medicine. https://doi.org/10.15252/emmm.201809288

Source records